- These are some of the biggest stock gainers of the day.
Quanergy Systems (QNGY) – Up 155.81%
Quanergy Systems recently filed an RFP for 9.8 million units at $1.53 per unit. And each unit consists of common stock and warrants.
Aeglea BioTherapeutics (AGLE) – Up 61.4%
Wells Fargo has upgraded Aeglea BioTherapeutics from an “Equal Weight” rating to “Overweight”. And the price target changed from $1.50 to $2.
Nuvalent (NUVL) – Up to 60.64%
BMO Capital analysts raise Nuvalent’s target price from $28 to $50. Assessment: market performance
Bull Horn Holdings (BHSE) – Up 43.98%
Pursuant to the requirements of the Securities Exchange Act of 1934, Nasdaq Stock Market LLC has certified that it has reasonable grounds to believe that it meets all of the requirements to file a Form 25.
Acquiring Endurance (SATX) – Up 40.49%
SatixFy Communications began trading on the NYSE after completing a special purpose acquisition company merger.
Fangdd Network Group Ltd (DUO) – Up 36.62%
N / A
Provident Acquisition Corp (PAQC) – Up 32.69%
Perfect Corp., a global leader in providing augmented reality (AR) and artificial intelligence (AI) software-as-a-service (SaaS) solutions to the beauty and fashion industries, and Provident Acquisition Corp. (PAQC), a special purpose acquisition company, have announced the completion of their previously announced business combination.
Viomi Technology (VIOT) – Up 24.97%
N / A
Data I/O (DAIO) – Up 23.38%
Q3 results – Net sales of $7.2 million; reservations of $7.1 million
HeartCore Enterprises (HTCR) – Up 23.18%
HeartCore Enterprises recently announced that it has signed an agreement with Transcosmos Digital Technology (TCDT) to license its advanced process mining tool Apromore. And under an exclusive reseller agreement for the Japanese market with Apromore, as part of its suite of strategic assets and arrangements, HeartCore is focused on helping Japanese companies accelerate their digital transformation.
Smart Sand Stock (SND) – Up 22.53%
N / A.
Oblong (OBLG) – Up 21.43%
N / A
8×8 (EGHT) – Up to 21.11%
Needham analysts have assigned the company a price target of $8 with a “Buy” rating.
CPI Aerostructures (CVU) – Up 20.47%
N / A
Seres Therapeutics (MCRB) up 19.73%
Results and operational progress will be announced on 2/11
Scholar Rock Holding (SRRK) – Up 19.64%
Invus Public Equities acquired 130,265 shares at $8.0404 each
DexCom (DXCM) – Up 19.38%
Third Quarter Earnings: DexCom reported third quarter EPS of $0.28, $0.04 higher than analyst estimates of $0.24. And revenue for the quarter was $769.6 million versus the consensus estimate of $751.74 million. And DexCom estimates fourth-quarter 2022 revenue at $2.88-2.91 billion, versus consensus of $2.89 billion.
NGM Biopharmaceuticals (NGM) – Up 17.36%
EcoR1 Capital, LLC’s regulatory filing shows an 8% stake in the company.
Pennymac Financial Services (PFSI) – Up 16.86%
Piper Sandler analysts raised PennyMac Financial’s price target to $82 from $78 and maintained an “overweight” rating for the company.
Verastem Oncologie (VSTM) – Up 17.14%
N / A
Assure Holdings (IONM) – Up 16.55%
Regulatory filings revealed that corporate directors had acquired a large number of shares.
ReTo Eco-Solutions (NQ: RETO) – Up 16.38%
The regulatory filing shows that the company may offer, issue and sell from time to time common stock, debt securities, warrants, rights or units up to $200 million or its equivalent in any other currency , currency unit or composite currency or currencies in one or more issues.
Third Harmonic Bio (THRD) – Up to 15.71%
Large number of warrants exercised by company executives
DURECT (DRRX) – Up 15.61%
N / A
Third Coast Bancshares (TCBX) – Up 15.48%
Deutsche Bank analysts have assigned the company a price target of $22 with a “Hold” rating.
Kinsale Capital Group (KNSL) – Up 15.22%
Kinsale Capital reported third-quarter EPS of $1.64, up $0.13 from analyst estimates of $1.51. And revenue for the quarter was $216.96 million versus the consensus estimate of $252.3 million.
AppFolio (APPF) – Up 15.21%
Third Quarter Results: Total revenue was $125.1 million in the third quarter of 2022, an increase of 31% from $95.8 million in the third quarter of 2021. revenue for the full year is expected to be between $462 and $466 million.
Athersys (NQ:ATHX) – Up to 15%
N / A